首页 | 本学科首页   官方微博 | 高级检索  
     

胸痹通胶囊治疗冠心病的临床观察
引用本文:王伟,唐可清,唐可欣,田立. 胸痹通胶囊治疗冠心病的临床观察[J]. 中西医结合心脑血管病杂志, 2006, 4(8): 663-665
作者姓名:王伟  唐可清  唐可欣  田立
作者单位:1. 山东烟台龙口市北海医院,265701
2. 山东省潍坊市中医院
3. 山东省潍坊医学院
摘    要:
目的 探讨胸痹通胶囊治疗冠心病的疗效及机制。方法 将96例冠心痛病人随机分为胸痹通胶囊组(治疗组)49例及心可舒组(对照组)47例,分别用胸痹通胶囊和心可舒治疗1个疗程,观察两组的临床疗效及血脂、血液流变学等指标。结果 经治疗1个疗程后治疗组临床症状,总有效率93.9%明显优于对照组的78.7%(P〈0.05)。治疗组治疗后胆固醇、三酰甘油均较治疗前有明显降低;治疗组血液流变学指标与治疗前比较,除红细胞比容、血沉外均有明显降低(P〈0.01)。结论 胸痹通胶囊对冠心病有良好的治疗效果,其作用优于心可舒。

关 键 词:胸痹通胶囊  冠心病  心可舒片
文章编号:1672-1349(2006)08-0663-03
修稿时间:2006-06-28

Effect and Mechanism of Xiongbitong Capsule on Coronary Heart Disease
Wang Wei,Tang Keqing,Tang Kexin,et al // Beihai Hospital,Yantai Longkou. Effect and Mechanism of Xiongbitong Capsule on Coronary Heart Disease[J]. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, 2006, 4(8): 663-665
Authors:Wang Wei  Tang Keqing  Tang Kexin  et al // Beihai Hospital  Yantai Longkou
Affiliation:Longkou 265701
Abstract:
Objective To observe the effects and the mechanism of Xiongbitong capsule on coronary heart disease. Methods Ninety-six cases were randomly divided into two groups:Xiongbitong capsule group treated with Xiongbitong and Xinkeshu group treated with Xinkeshu for a month.Results The effective rate of Xiongbitong capsule group and Xinkeshu group were 93.9% and 78.7%,respectively,and the difference was significant(P<0.05).Conclusion Xiongbitong capsule was effective for coronary heart disease, and its effect was better than that of Xinkeshu.
Keywords:Xiongbitong capsule  coronary heart disease  Xinkeshu capsule
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号